Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

March 31, 2007

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL

BHT-3009-01

Trial Locations (4)

Barrow Neurology Clinics, Phoenix

USC, LAC & USC Medical Center, Los Angeles

University of British Columbia, MS Research, Vancouver

Montreal Neurological Institute, Clinical Research Unit and MS clinic, Montreal